Amunix | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

75 results for “Amunix”

Trials

View all 50 →

Auditory Deficits in Congenital Amusia (AMUSIE CONGENITALE)

230 participants · First posted Mar 29, 2017

MUNIX Variability in Healthy Subjects

120 participants · First posted Jul 20, 2018

Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer

100 participants · First posted Mar 9, 2021

Drugs

IL-12 XPAC program (Amunix)

anti-CD3/undisclosed target 3 bispecific T-cell engager XPAT/Pro-XTEN (Amunix)

Investigational

AGuIX

Organizations

axunio Pharma GmbH

Germany

Aminex Therapeutics, Inc.

United States

Amnio Technology, LLC

United States

News

View all 12 →

Genentech Advances RO-7759065 Development for Metastatic Solid Tumors

Vir Biotechnology Appoints Timothy Coughlin to Board of Directors Amid Pipeline Advancement

Omega Funds Closes Oversubscribed $647M Fund VIII to Accelerate Life Sciences Innovation

Page 1 of 8